GB1457005A - 2-substituted-3-aminoquinoxalines - Google Patents

2-substituted-3-aminoquinoxalines

Info

Publication number
GB1457005A
GB1457005A GB5293673A GB5293673A GB1457005A GB 1457005 A GB1457005 A GB 1457005A GB 5293673 A GB5293673 A GB 5293673A GB 5293673 A GB5293673 A GB 5293673A GB 1457005 A GB1457005 A GB 1457005A
Authority
GB
United Kingdom
Prior art keywords
alkyl
compounds
piperazino
nrr
hydroxyalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5293673A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Inc
Original Assignee
Pfizer Corp Belgium
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Inc filed Critical Pfizer Corp Belgium
Publication of GB1457005A publication Critical patent/GB1457005A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB5293673A 1972-11-20 1973-11-14 2-substituted-3-aminoquinoxalines Expired GB1457005A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30816872A 1972-11-20 1972-11-20
US41021473A 1973-10-26 1973-10-26

Publications (1)

Publication Number Publication Date
GB1457005A true GB1457005A (en) 1976-12-01

Family

ID=26976126

Family Applications (2)

Application Number Title Priority Date Filing Date
GB5293673A Expired GB1457005A (en) 1972-11-20 1973-11-14 2-substituted-3-aminoquinoxalines
GB3198676A Expired GB1457400A (en) 1972-11-20 1973-11-14 Pharmaceutical compositions containing 2-substituted quinoxa lines

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB3198676A Expired GB1457400A (en) 1972-11-20 1973-11-14 Pharmaceutical compositions containing 2-substituted quinoxa lines

Country Status (5)

Country Link
JP (1) JPS554100B2 (cs)
DE (1) DE2357186A1 (cs)
FR (1) FR2206951B1 (cs)
GB (2) GB1457005A (cs)
NL (1) NL7315808A (cs)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465467B1 (en) 1999-05-21 2002-10-15 Biovitrum Ab Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
WO2004000830A1 (en) 2002-06-19 2003-12-31 Biovitrum Ab Novel compounds, their use and preparation

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI193974A7 (cs) * 1973-07-13 1975-01-14 Merck & Co Inc
DE2730644A1 (de) * 1977-07-07 1979-01-25 Bayer Ag Fluoreszenz-farbstoffe
WO1999042461A1 (en) * 1998-02-23 1999-08-26 Warner-Lambert Company Substituted quinoxaline derivatives as interleukin-8 receptor antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2107301A1 (de) * 1970-02-25 1971-09-09 CIBA Geigy AG, Basel (Schweiz) Neue heterocyclische Verbindungen und Verfahren zu ihrer Herstellung

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465467B1 (en) 1999-05-21 2002-10-15 Biovitrum Ab Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
US7071180B2 (en) 1999-05-21 2006-07-04 Biovitrum Ab Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
US7534794B2 (en) 1999-05-21 2009-05-19 Biovitrum Ab Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
WO2004000830A1 (en) 2002-06-19 2003-12-31 Biovitrum Ab Novel compounds, their use and preparation

Also Published As

Publication number Publication date
JPS49133384A (cs) 1974-12-21
DE2357186A1 (de) 1974-05-22
JPS554100B2 (cs) 1980-01-29
GB1457400A (en) 1976-12-01
FR2206951B1 (cs) 1976-10-22
NL7315808A (cs) 1974-05-22
FR2206951A1 (cs) 1974-06-14

Similar Documents

Publication Publication Date Title
GB1309835A (en) Trialkoxy-quinazolines
GB1309182A (en) Pyrimidine derivatives
GB1457005A (en) 2-substituted-3-aminoquinoxalines
IE38979L (en) Tetrazolyl - quinoxalinecarboxamide derivatives
GB1260768A (en) N-alkyl-tetrahydrocarbazoles
ES431497A1 (es) Procedimiento para preparar un derivado de s-triazol (1,5- a) piridina.
GB1363195A (en) Propenylamine derivatives and process for the production thereof
GB1342828A (en) Pyrimidinyl-piperazines and processes for their preparation
GB1530413A (en) 5,8-dihydro-5-oxopyrido(2,3-d)pyrimidines
GB1466493A (en) 1-h-tetrazole derivatives
GB1179108A (en) New Derivatives of Dibenzo (c,f) Thiazepine (1,2) and processes for manufacturing them
GB1258797A (cs)
GB1432660A (en) Piperazine derivatives processes for their preparation and and pharamacueitcal compositions containing them
GB1503180A (en) 1,2,4-benzothiadiazine 1,1-dioxide
GB1175617A (en) Substituted Pteridine Derivatives
GB1394757A (en) Lysino-calcium chloride
GB1314899A (en) Thiosemicarbazones processes for their preparations and compositions incorporating them
GB1514225A (en) Paracetamol derivatives
GB1175907A (en) Substituted Pteridine Derivatives
GB1505525A (en) Pyridopyrimidines
GB1171827A (en) Improvements in or relating to Substituted Propanols and the Manufacture thereof
GB1139146A (en) Benzofuran derivatives and processes for preparing the same
GB1477996A (en) Quinolizine derivatives and their preparation
GB1362400A (en) 1-amino-isoquinoline derivatives
GB1324676A (en) Derivatives of 1,7,7-trimethyl-2-norbornane-2-spiro-1,3-dioxolane their process of preparation and their therapeutic application

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee